T细胞在天疱疮发病机制中的研究进展

doi:10.35541/cjd.20240023

Abstract

Abstract: 【Abstract】 Pemphigus is a group of life-threatening chronic autoimmune blistering diseases. It is currently believed that the humoral immunity mediated by anti-desmoglein IgG antibodies is the primary mechanism underlying the pathogenesis of pemphigus. However, recent studies have indicated a critical role of various T cell subsets in the onset of pemphigus.

Key words: Pemphigus, Desmogleins, CD4-positive T-lymphocytes, CD8-positive T-lymphocytes, T-lymphocytes, regulatory, T-lymphocytes, helper-inducer

Tang Dongmei, Yan Yurou, Xu Yinde, Li Xiaolan. Role of T cells in the pathogenesis of pemphigus[J]. Chinese Journal of Dermatology, 2024, 57(10): 955-959.doi:10.35541/cjd.20240023

References ［48］

［1］	Araghi F, Dadkhahfar S, Robati RM, et al. The emerging role of T cells in pemphigus vulgaris: a systematic review［J］. Clin Exp Med, 2023,23（4）:1045⁃1054. doi: 10.1007/s10238⁃022⁃00855⁃8.
［2］	Yuan Q, Yang W, Zhang X. Immune cells in pemphigus vulgaris and bullous pemphigoid: from pathogenic roles to targeting therapies［J］. Int Immunopharmacol, 2023,123:110694. doi: 10. 1016/j.intimp.2023.110694.
［3］	Takahashi H, Iriki H, Asahina Y. T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen［J］. J Dermatol, 2023,50（2）:112⁃123. doi: 10.1111/1346⁃8138.16663.
［4］	Khantakova JN, Sennikov SV. T⁃helper cells flexibility: the possibility of reprogramming T cells fate［J］. Front Immunol, 2023,14:1284178. doi: 10.3389/fimmu.2023.1284178.
［5］	Butcher MJ, Zhu J. Recent advances in understanding the Th1/Th2 effector choice［J］. Fac Rev, 2021,10:30. doi: 10.12703/r/10⁃30.
［6］	Hertweck A, Vila de Mucha M, Barber PR, et al. The TH1 cell lineage⁃determining transcription factor T⁃bet suppresses TH2 gene expression by redistributing GATA3 away from TH2 genes［J］. Nucleic Acids Res, 2022,50（8）:4557⁃4573. doi: 10.1093/nar/gkac258.
［7］	Liu Q, Cui F, Wang M, et al. Increased expression of microRNA⁃338⁃3p contributes to production of Dsg3 antibody in pemphigus vulgaris patients［J］. Mol Med Rep, 2018,18（1）:550⁃556. doi: 10.3892/mmr.2018.8934.
［8］	Chen J, Zhang Y, Liang Y, et al. Regulatory effects of Nr4a2 on Th2 cells from patients with pemphigus vulgaris［J］. Oncotarget, 2018,9（13）:11258⁃11267. doi: 10.18632/oncotarget.24371.
［9］	田晶, 梁源, 申春平, 等. 儿童中重度特应性皮炎首次皮下注射度普利尤单抗短期疗效和安全性分析［J］. 中华皮肤科杂志, 2022,55（4）:299⁃303. doi: 10.35541/cjd.20210734.
［10］	Jiang C, Adjei S, Santiago S, et al. Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus［J］. JAAD Case Rep, 2023,42:12⁃15. doi: 10.1016/j.jdcr.2023.09.018.
［11］	Moore AY, Hurley K. Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris［J］. JAAD Case Rep, 2023,31:16⁃18. doi: 10.1016/j.jdcr.2022.10.035.
［12］	Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases［J］. Semin Immunopathol, 2019,41（3）:283⁃297. doi: 10.1007/s00281⁃019⁃00733⁃8.
［13］	Schinner J, Cunha T, Mayer JU, et al. Skin⁃infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris［J］. Front Immunol, 2023,14:1203776. doi: 10.3389/fimmu.2023.1203776.
［14］	Ansari MA, Singh PK, Dar SA, et al. Deregulated phenotype of autoreactive Th17 and Treg clone cells in pemphigus vulgaris after in⁃vitro treatment with desmoglein antigen （Dsg⁃3）［J］. Immunobiology, 2023,228（2）:152340. doi: 10.1016/j.imbio.2023. 152340.
［15］	Holstein J, Solimani F, Baum C, et al. Immunophenotyping in pemphigus reveals a T（H）17/T（FH）17 cell⁃dominated immune response promoting desmoglein1/3⁃specific autoantibody production［J］. J Allergy Clin Immunol, 2021,147（6）:2358⁃2369. doi: 10. 1016/j.jaci.2020.11.008.
［16］	Xu C, Zhang T, Wang H, et al. Integrative single⁃cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus［J］. J Autoimmun, 2024,142:103128. doi: 10.1016/j.jaut.2023.103128.
［17］	Chen Y, Wang YF, Song SS, et al. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL⁃17 signaling pathway and Th17 cell differentiation［J］. J Ethnopharmacol, 2022,296:115496. doi: 10.1016/j.jep.2022.115496.
［18］	Tada Y, Morita A, Yamanaka K, et al. Real⁃world retention rates and effectiveness of secukinumab in psoriasis: results from a multicenter cohort study （RAILWAY）［J］. J Dermatol, 2023,50（11）:1415⁃1426. doi: 10.1111/1346⁃8138.16926.
［19］	Kohlmann J, Simon JC, Kunz M, et al. Possible effect of interleukin⁃17 blockade in pemphigus foliaceus and neutrophilic diseases［J］. Hautarzt, 2019,70（8）:641⁃644. doi: 10.1007/s00105⁃019⁃4414⁃8.
［20］	Lin X, Chen M, Li X, et al. Low SOCS3 expression in CD4（+） T cells from pemphigus vulgaris patients enhanced Th1⁃ and Th17⁃cell differentiation and exacerbated acantholysis via STAT activation［J］. Mol Immunol, 2022,150:114⁃125. doi: 10.1016/j.molimm.2022.08.007.
［21］	Singh PK, Das S, Rai G, et al. A snapshot of T cell subset cytokines in pemphigus vulgaris: a cross⁃sectional study［J］. Cureus, 2022,14（10）:e29890. doi: 10.7759/cureus.29890.
［22］	Attias M, Al⁃Aubodah T, Piccirillo CA. Mechanisms of human FoxP3（+） T（reg） cell development and function in health and disease［J］. Clin Exp Immunol, 2019,197（1）:36⁃51. doi: 10. 1111/cei.13290.
［23］	Abd El⁃Magid WM, Ahmed SF, Assaf H, et al. Immunohistochemical expression of regulatory T cells （CD（4）（+） CD（25）（+） bright FOXP（3）（+）） in pemphigus patients［J］. J Cosmet Dermatol, 2022,21（10）:4871⁃4876. doi: 10.1111/jocd.14854.
［24］	Iriki H, Takahashi H, Amagai M. Diverse role of OX40 on T cells as a therapeutic target for skin diseases［J］. J Invest Dermatol, 2023,143（4）:545⁃553. doi: 10.1016/j.jid.2022.11.009.
［25］	Xu M, Liu Q, Li S, et al. Increased expression of miR⁃338⁃3p impairs Treg⁃mediated immunosuppression in pemphigus vulgaris by targeting RUNX1［J］. Exp Dermatol, 2020,29（7）:623⁃629. doi: 10.1111/exd.14111.
［26］	Lai K, Zhang W, Li S, et al. mTOR pathway regulates the differentiation of peripheral blood Th2/Treg cell subsets in patients with pemphigus vulgaris［J］. Acta Biochim Biophys Sin （Shanghai）, 2021,53（4）:438⁃445. doi: 10.1093/abbs/gmab008.
［27］	Qi J, Liu C, Bai Z, et al. T follicular helper cells and T follicular regulatory cells in autoimmune diseases［J］. Front Immunol, 2023,14:1178792. doi: 10.3389/fimmu.2023.1178792.
［28］	Mesas⁃Fernández A, Bodner E, Hilke FJ, et al. Interleukin⁃21 in autoimmune and inflammatory skin diseases［J］. Eur J Immunol, 2023,53（4）:e2250075. doi: 10.1002/eji.202250075.
［29］	Wei X, Niu X. T follicular helper cells in autoimmune diseases［J］. J Autoimmun, 2023,134:102976. doi: 10.1016/j.jaut.2022. 102976.
［30］	Hennerici T, Pollmann R, Schmidt T, et al. Increased frequency of T follicular helper cells and elevated interleukin⁃27 plasma levels in patients with pemphigus［J/OL］. PLoS One, 2016,11（2）:e0148919. doi: 10.1371/journal.pone.0148919.
［31］	Maho⁃Vaillant M, Perals C, Golinski ML, et al. Rituximab and corticosteroid effect on desmoglein⁃specific B cells and desmoglein⁃specific T follicular helper cells in pemphigus［J］. J Invest Dermatol, 2021,141（9）:2132⁃2140.e1. doi: 10.1016/j.jid.2021.01.031.
［32］	Wang C, Zhang H, Liu T, et al. Circulating Tfr/Tfh cell imbalance may contribute to the immunopathogenesis of pemphigus［J］. J Eur Acad Dermatol Venereol, 2023,37（12）:e1399⁃e1402. doi: 10.1111/jdv.19338.
［33］	Kim AR, Han D, Choi JY, et al. Targeting inducible costimulator expressed on CXCR5（+）PD⁃1（+） T（H） cells suppresses the progression of pemphigus vulgaris［J］. J Allergy Clin Immunol, 2020,146（5）:1070⁃1079.e8. doi: 10.1016/j.jaci.2020.03.036.
［34］	Sun L, Su Y, Jiao A, et al. T cells in health and disease［J］. Signal Transduct Target Ther, 2023,8（1）:235. doi: 10.1038/s41392⁃023⁃01471⁃y.
［35］	Moon JS, Younis S, Ramadoss NS, et al. Cytotoxic CD8（+） T cells target citrullinated antigens in rheumatoid arthritis［J］. Nat Commun, 2023,14（1）:319. doi: 10.1038/s41467⁃022⁃35264⁃8.
［36］	Li H, Tsokos GC. Double⁃negative T cells in autoimmune diseases［J］. Curr Opin Rheumatol, 2021,33（2）:163⁃172. doi: 10.1097/BOR.0000000000000778.
［37］	Murayama K, Ikegami I, Kamekura R, et al. CD4（+）CD8（+） T follicular helper cells regulate humoral immunity in chronic inflammatory lesions［J］. Front Immunol, 2022,13:941385. doi: 10.3389/fimmu.2022.941385.
［38］	Bhanusali DG, Sachdev A, Rahmanian A, et al. HLA⁃E*0103X is associated with susceptibility to pemphigus vulgaris［J］. Exp Dermatol, 2013,22（2）:108⁃112. doi: 10.1111/exd.12077.
［39］	El⁃Naby SE⁃SA, Amin M, Ali MH, et al. Evaluation of the relation between T⁃lymphocytes （CD4 ve and CD8 ve） and pemphigus vulgaris pathogenesis and severity［J］. Indian J Dermatopathol Diagn Dermatol, 2019,6（1）:30⁃35. doi: 10.4103/ijdpdd.ijdpdd_70_18.
［40］	Giurdanella F, Fania L, Gnarra M, et al. A possible role for CD8+ T lymphocytes in the cell⁃mediated pathogenesis of pemphigus vulgaris［J］. Mediators Inflamm, 2013,2013:764290. doi: 10.1155/2013/764290.
［41］	Muro R, Takayanagi H, Nitta T. T cell receptor signaling for γδT cell development［J］. Inflamm Regen, 2019,39:6. doi: 10.1186/s41232⁃019⁃0095⁃z.
［42］	Das D, Anand V, Khandpur S, et al. T helper type 1 polarizing γδ T cells and scavenger receptors contribute to the pathogenesis of pemphigus vulgaris［J］. Immunology, 2018,153（1）:97⁃104. doi: 10.1111/imm.12814.
［43］	Das D, Arava S, Khandpur S, et al. Dominance and improved survivability of human γδT17 cell subset aggravates the immunopathogenesis of pemphigus vulgaris［J］. Immunol Res, 2024,72（1）:72⁃81. doi: 10.1007/s12026⁃023⁃09413⁃0.
［44］	Fazeli P, Kalani M, Hosseini M. T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values［J］. Front Immunol, 2023,14:1204231. doi: 10.3389/fimmu.2023.1204231.
［45］	Emmanuel T, Mistegård J, Bregnhøj A, et al. Tissue⁃resident memory T cells in skin diseases: a systematic review［J］. Int J Mol Sci, 2021,22（16）:9004. doi: 10.3390/ijms22169004.
［46］	Karagaiah P, Schwartz RA, Lotti T, et al. Biologic and targeted therapeutics in vitiligo［J］. J Cosmet Dermatol, 2023,22（1）:64⁃73. doi: 10.1111/jocd.14770.
［47］	Richmond JM, Strassner JP, Rashighi M, et al. Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo［J］. J Invest Dermatol, 2019,139（4）:769⁃778. doi: 10.1016/j.jid.2018.10.032.
［48］	Zou Y, Yuan H, Zhou S, et al. The Pathogenic role of CD4+ tissue⁃resident memory T cells bearing T follicular helper⁃like phenotype in pemphigus lesions［J］. J Invest Dermatol, 2021,141（9）:2141⁃2150. doi: 10.1016/j.jid.2021.01.030.

[1]	Song Yuqing, Yang Nan, Liu Linlin, Feng Ziyi, Han Shixin, Zhou Meijuan. Dermabrasion for the treatment of familial benign chronic pemphigus: a clinical observation of 6 cases [J]. Chinese Journal of Dermatology, 2024, 57(8): 743-746.
[2]	Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming. Pathogenesis and targeted therapy of pemphigus [J]. Chinese Journal of Dermatology, 2024, 57(4): 374-378.
[3]	Guo Lei, Cao Chunyan, Fang Xiaoya, Feng Suying. Analysis of current status and risk factors of multidrug-resistant bacteria wound infections in patients with autoimmune bullous diseases [J]. Chinese Journal of Dermatology, 2024, 57(2): 155-160.
[4]	Pan Meng, Wang Qijun. Challenges and strategies for the treatment of pemphigus vulgaris [J]. Chinese Journal of Dermatology, 2024, 57(10): 891-894.
[5]	China Dermatologist Association, Treatment Group, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases, Rare Skin Diseases Committee, China Alliance for Rare Diseases. Guidelines for diagnosis and treatment of pemphigus in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(10): 873-886.
[6]	Shan Ying, Chang Xiaotong, Zuo Yagang. Epitope spreading in autoimmune bullous diseases [J]. Chinese Journal of Dermatology, 2023, 56(7): 702-705.
[7]	China Dermatologist Association, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases. Consensus on health education of patients with pemphigus （2023） [J]. Chinese Journal of Dermatology, 2023, 0(4): 20230123-e20230123.
[8]	Sun Yujiao, Wang Jianbo, Duan Ziyu, Dou Jinfa, Li Yan, Li Jianguo, Zhang Shoumin. Detection of ATP2C1 gene mutations in a family with generalized familial benign chronic pemphigus [J]. Chinese Journal of Dermatology, 2023, 56(4): 335-337.
[9]	Wan Li, Hu Bin, Luo Hongyu, Fang Meizhen, Han Lijuan, Chen Qiang, Zhou Xiaoyong, Chen Liuqing, Chen Jinbo. Clinical characteristics and treatment of eight cases of pemphigus/bullous pemphigoid complicated by herpes simplex virus infection [J]. Chinese Journal of Dermatology, 2023, 56(3): 229-233.
[10]	Zheng Jingbing, Han Huimin, Wang Shan, Sun Qian. Changes in CD100 expression and its regulation on CD8⁺ T cell function in peripheral blood of patients with herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(3): 234-240.
[11]	Wang Qian, Jiang Shui, Zou Yaru, Chen Hongquan, Chen Guanzhi, Yu Bo, Zou Hui, Chu Xin. Considerations during the treatment of pemphigus vulgaris under special circumstances [J]. Chinese Journal of Dermatology, 2023, 56(11): 1078-1080.
[12]	Cao Miao, Chong Shan, Wang Mingyue. Effect of different immersion bath methods on the healing of skin lesions in patients with pemphigus [J]. Chinese Journal of Dermatology, 2023, 56(1): 49-53.
[13]	Fan Birao, Chen Xixue, Wang Mingyue. Retrospective analysis of efficacy and safety of minocycline alone or in combination with low-dose glucocorticoids in the treatment of 15 cases of pemphigus erythematosus and 9 cases of pemphigus herpetiformis [J]. Chinese Journal of Dermatology, 2022, 55(8): 676-681.
[14]	Cao Miao, Chong Shan, Hu Xinyuan, Zhu Xuejun, Wang Mingyue. Analysis of skin and mucosal infections and their management after primary tumor resection in patients with paraneoplastic pemphigus [J]. Chinese Journal of Dermatology, 2022, 55(8): 669-675.
[15]	Zhang Hanmei, Feng Suying. Pemphigus complicated by herpes simplex virus infection [J]. Chinese Journal of Dermatology, 2022, 55(6): 545-548.

Role of T cells in the pathogenesis of pemphigus

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［48］

Related Articles 15

Metrics

Comments

Recommended 10